Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on ATR Inhibitors. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel 8-oxa-3-azabicyclo[3.2.1]octane compounds for ATR inhibition. Enhanced solubility and metabolic stability for oncology drug development and supply chain optimization.
Patent CN1495164A details a Rh-catalyzed route to chiral lactones. Offers high ee and scalable process for MMP inhibitor intermediates.
Patent CN1160350C details a rhodium-catalyzed route for high-purity chiral lactones, offering significant cost reduction in API manufacturing and reliable supply chain continuity.